Particle size plays a critical role in the performance, solubility, bioavailability, and stability of Active Pharmaceutical Ingredients (APIs). In many pharmaceutical formulations, controlling particle size is essential to achieving consistent product performance and meeting specific formulation requirements.
API micronisation is a precision particle size reduction process used to produce fine and uniform API particles. By reducing particle size, the available surface area of the material increases, which can support improved dissolution and more consistent formulation performance. This makes micronisation particularly valuable for APIs where particle size directly influences the behavior of the final drug product.
At K N Finetech, precision micronisation is supported by advanced technology and extensive pharmaceutical experience. Our technology can achieve 100% of particles below 10 microns, allowing us to address demanding particle-size requirements.
With 17+ years of pharmaceutical micronisation experience, cleanroom operations, stringent quality controls, and an ISO 9001:2015 Quality Management System, K N Finetech focuses on delivering consistent, contamination-free, and specification-driven micronized powders.
For pharmaceutical manufacturers, choosing the right micronisation partner can help improve process consistency, product quality, and formulation performance.